Recent research emphasizes the capability of MSC-Exos to deliver antioxidant enzymes, microRNAs, and iron-regulating molecules [11], positioning them as promising candidates for targeting ferroptosis
Together, these systems help protect retinal cells and support lens clarity, helping maintain healthy vision over time
Recent reports have shown that GLP-1 receptor agonists such as liraglutide and semaglutide, which are currently approved for treating type 2 diabetes, decrease alcohol-seeking behaviors by inhibiting the mesolimbic reward system of the brain
There is no established GLP-3 peptide or receptor in human physiology
The KLOW stack peptide combines GHK-Cu (glycyl-L-histidyl-L-lysine copper complex, 50mg), BPC-157 (body protection compound 15-mer, 10mg), TB-500 (synthetic Thymosin Beta-4 analogue, 10mg), and KPV (Lys-Pro-Val C-terminal alpha-MSH tripeptide, 10mg) in a single co-lyophilized 80mg vial
What We Know So Far: Tissue repair: Preclinical studies show accelerated healing of tendons, ligaments, and muscle through enhanced angiogenesis ( VEGF), collagen synthesis, and fibroblast activity